Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 590371-73-6 | MDL No. : | MFCD08234939 |
Formula : | C6H3F3IN | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | OYQSAEIWDLIZHC-UHFFFAOYSA-N |
M.W : | 272.99 | Pubchem ID : | 23436940 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.96 |
TPSA : | 12.89 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.25 cm/s |
Log Po/w (iLOGP) : | 1.91 |
Log Po/w (XLOGP3) : | 2.42 |
Log Po/w (WLOGP) : | 3.86 |
Log Po/w (MLOGP) : | 2.49 |
Log Po/w (SILICOS-IT) : | 3.34 |
Consensus Log Po/w : | 2.8 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.39 |
Solubility : | 0.11 mg/ml ; 0.000403 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.33 |
Solubility : | 1.27 mg/ml ; 0.00464 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.86 |
Solubility : | 0.0376 mg/ml ; 0.000138 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.61 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H227-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
146 mg | Stage #1: With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; sodium hydrogencarbonate In tetrahydrofuran at 120℃; for 20 h; Stage #2: With hydrogenchloride; water In water at 20℃; for 1 h; |
Example 9 Preparation of 2-Trifluoromethyl-isonicotinic acid from 4-Chloro-2-trifluoromethyl pyridine A mixture of 182 mg (1.0 mmol) 4-Chloro-2-trifluoromethyl pyridine, 18.0 mg PdCl2(dppp) and 210 mg sodium hydro gencarbonate in 1.5 ml THF and 1.5 ml water was stirred under 70 bar CO for 20 hour at 120°C, THF was removed under reduced pressure, 0.5 ml 2M NaOH was added and the suspension was filtered. The clear solution was treated with 0.52 ml hydrochloric acid 25 percent, stirred for lh at rt, filtered and the white crystals were dried at 40°C, to obtain 146 mg 2-trifluoromethyl-isonicotinic acid. GC-EI-MS: M 191+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
32% | With n-butyllithium; diisopropylamine In tetrahydrofuran; hexane at -78℃; for 2 h; Cooling with acetone-dry ice | A 2.5M solution of BuLi in hexane (7.2 mL) was diluted in THF (30 mL) and cooled to -780C (dry ice/acetone). To this solution were subsequently and dropwise added 1Pr2NH (2.5 mL) and the title compound from Step A above (4.9 g). The mixture was stirred at -78°C for 2 h, quenched at -780C with MeOH (2 mL), concentrated and purified by EPO <DP n="159"/>chromatography (silica, cyclohexane/EtOAc) to afford the title compound as yellow needles (1.6 g, 32percent). 1H-NMR (CDCl3) D= 8.40 (d, 1 H), 8.06 (s, 1 H), 7.90 (d, 1 H). |
[ 873107-98-3 ]
5-Iodo-2-(trifluoromethyl)pyridine
Similarity: 0.86
[ 823221-95-0 ]
5-Chloro-4-iodo-2-(trifluoromethyl)pyridine
Similarity: 0.83
[ 1620-71-9 ]
5-Methyl-2-(trifluoromethyl)pyridine
Similarity: 0.75
[ 1239462-10-2 ]
5-Iodo-2-(trifluoromethyl)pyridin-4-amine
Similarity: 0.74
[ 1030632-94-0 ]
5-Ethyl-2-(trifluoromethyl)pyridine
Similarity: 0.74
[ 873107-98-3 ]
5-Iodo-2-(trifluoromethyl)pyridine
Similarity: 0.86
[ 823221-95-0 ]
5-Chloro-4-iodo-2-(trifluoromethyl)pyridine
Similarity: 0.83
[ 1620-71-9 ]
5-Methyl-2-(trifluoromethyl)pyridine
Similarity: 0.75
[ 1239462-10-2 ]
5-Iodo-2-(trifluoromethyl)pyridin-4-amine
Similarity: 0.74
[ 1030632-94-0 ]
5-Ethyl-2-(trifluoromethyl)pyridine
Similarity: 0.74
[ 873107-98-3 ]
5-Iodo-2-(trifluoromethyl)pyridine
Similarity: 0.86
[ 823221-95-0 ]
5-Chloro-4-iodo-2-(trifluoromethyl)pyridine
Similarity: 0.83
[ 1620-71-9 ]
5-Methyl-2-(trifluoromethyl)pyridine
Similarity: 0.75
[ 1239462-10-2 ]
5-Iodo-2-(trifluoromethyl)pyridin-4-amine
Similarity: 0.74